Every Drug Analog. Every source. In minutes.
The Drug Analog Digital Knowledge Worker automates the analog research, competitive intelligence and benchmarking work that pharma and CRO commercial teams rely on, across every public and licensed drug data source, with every fact cited to source.
Every drug analog. Every source. In minutes.
The Drug Analog Digital Knowledge Worker automates the analog research, competitive intelligence and benchmarking work that pharma and CRO commercial teams rely on, across every public and licensed drug data source, with every fact cited to source.
Drug analog research is broken in 3 predictable ways
1) The analog search takes too longs
A senior consultant opens more than ten tabs: OpenFDA, the Orange Book, the Purple Book, ChEMBL, ClinicalTrials.gov, RxClass, drug labels, licensed sources — and stitches the picture together by hand. Days per query. Often a full week for a defensible longlist. Project capacity is capped by analyst time.
2) Two analysts, two different answers
There is no standard methodology, no shared benchmark for accuracy, no reproducibility test. When a client challenges the analog set or the conclusions drawn from it, there is no audit trail to defend the work.
3) Source conflicts get silently resolved
When OpenFDA and the Orange Book disagree, an analyst picks one. The conflict — and the judgment call behind it — disappears into a cell in a slide. Risk is hidden, decisions are weakened, and the next analyst to look at the file has no idea what was reconciled and why.
From a week of analog research to minutes of review
Days → minutes
Time to a defensible analog cohort
10+
Drug data sources, queried in one workflow
100%
Of facts cited to the source, conflicts surfaced
- Drug analog research is the foundation of pre-launch forecasting, competitive positioning and market access strategy in biopharma.
- Today, it is done manually — by senior consultants, across ten-plus disconnected data sources.
- This Digital Worker replaces that effort entirely. It delivers a governed, fully cited workflow in minutes. Your team focuses on judgment, not data gathering.
Ask in plain English. Get a fully cited analog cohort in minutes.
- The Drug Analog Digital Knowledge Worker is built for commercial consultants and analysts, not engineers.
- It takes a question in natural language, plans how to answer it, queries every relevant source in parallel, and returns a sortable, downloadable analog cohort with every fact referenced back to its source.
1) Ask in plain English
“Find every analog for [asset] by mechanism of action, US-approved, last five years.” The Worker extracts the constraints automatically — indication, mechanism of action, route of administration, timeframe, geography, approval status — and shows you what it understood before it runs.
2) Configure guardrails, or accept the defaults
Every query starts with sensible defaults: US only, approved products, your source whitelist. Inspect them, adjust them, save them as a new configuration. Scoping stays consistent across every query and every consultant.
3) Watch the plan, not just the answer
The Worker shows the query plan and the source selection report before it runs — which sources, in what order, and why. No black box. Reviewers can challenge the plan upfront, not the output after the fact.
4) Get a fully cited cohort
A sortable, filterable longlist of drug analogs. Every field references the source it came from. Narrow to a shortlist by indication, treatment path, market size or time to market. Download as a table for downstream use in forecasting models, payer engagement materials or client decks.
5) Conflicts surfaced, not hidden
When sources disagree, the Worker flags the conflict explicitly and shows you the underlying evidence. The consultant decides with full context. Nothing is silently reconciled into a single number.
6) Reproducible and benchmarked
Accuracy and reproducibility are measured continuously against curated reference queries. Every release ships against an automated benchmark suite. The methodology doesn’t drift between analysts, between weeks, or between client engagements.
Every public source, every licensed source, in one workflow.
The Worker connects to the data sources commercial teams actually use, including:
New sources are added on request as part of a deployment.
Built for regulated commercial work.
Versus manual effort
Days become minutes. The methodology is benchmarked and reproducible — it doesn’t vary by analyst, by week, or by client engagement. Capacity stops scaling linearly with headcount.
Versus generic LLM tools
Every fact cited. Conflicts surfaced. Accuracy measured continuously. Guardrails configurable. Built for the scrutiny of regulated workflows.
Versus data vendors
Specialist vendors give you the data. We give you the synthesis — governed, explainable, and reusable across every commercial use case your team owns.
Built on causal reasoning
Pioneers of causal AI. Our Digital Workers combine causal reasoning with multi-agent automation — built for high-stakes, regulated environments.
A multi-agent workflow, purpose-built for regulated commercial research
The Drug Analog Digital Knowledge Worker is a multi-agentic system. Each agent has a single, inspectable job. Reliability, citations and conflict handling are first-class — not afterthoughts.
The Multi-Agent Workflow:
Parses the consultant’s natural-language question into hard and soft constraints — indication, mechanism of action, route of administration, timeframe, geography, approval status. Shows the extracted signals back to the user for review.
Integrations:
- Drug and clinical data sources
- Internal commercial data repositories and document stores
- Your approved large language model — we are model-agnostic and bring-your-own-LLM
- Deployment on causaLens cloud, your private cloud, or fully on-premise
What It Replaces & Reduces:
- Multi-day analyst research cycles across more than ten sources
- Manual reconciliation of conflicting source data
- Ad-hoc, non-reproducible analog methodologies that vary between analysts
- Lack of audit trail when clients or regulators challenge an analog set
Common questions, answered
Out of the box: OpenFDA and FDA drug labels, Orange Book, Purple Book, ChEMBL, ClinicalTrials.gov, RxClass, Citeline, Cortellis, OpenPayments, Orphanet and Drugs.com. We add internal repositories and additional licensed sources as part of a deployment.
Generic LLMs are not built for regulated commercial workflows. The Drug Analog Digital Knowledge Worker cites every fact to source, surfaces source conflicts explicitly rather than hiding them, applies configurable guardrails consistently across every query, and is benchmarked continuously for accuracy and reproducibility. It is governed, auditable and production-ready — not a chat interface.
Yes. We deploy on causaLens cloud, your private cloud, or fully on-premise. The Worker is model-agnostic — use our default model, or bring your own approved LLM. Your data never leaves your environment unless you choose otherwise.
Accuracy and reproducibility are measured continuously against curated reference queries built with your team. The benchmark suite runs against every release. We share the benchmark methodology and results during deployment.
Typical timeline: an MVP in two to three weeks against a small set of priority questions, followed by a production deployment scoped to your data, security and integration requirements. A dedicated causaLens AI engineer builds and runs the Worker; a causaLens value engineer owns project success.
Commercial consultants, forecasting analysts, competitive intelligence leads, market access strategists and launch teams. No engineering or data science background required. The interface is built for the questions consultants actually ask.